Ann Arbor, MI, United States of America

Daniel Rhodes

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 8.6

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Rhodes

Introduction

Daniel Rhodes is a prominent inventor based in Ann Arbor, MI (US), known for his significant contributions to the field of cancer research. With a total of 10 patents to his name, Rhodes has made remarkable strides in understanding gene fusions and variants associated with various cancer types. His work has implications for diagnosis, research, and therapy, making him a key figure in the scientific community.

Latest Patents

Rhodes' latest patents include groundbreaking discoveries such as "Gene fusions and gene variants associated with cancer." This patent provides insights into gene fusions, gene variants, and novel associations with disease states, along with kits, probes, and methods for their application. Another notable patent is "Recurrent gene fusions in prostate cancer," which describes recurrent gene fusions of androgen-regulated genes and ETS family member genes in prostate cancer. This work offers compositions and methods that have utility in prostate cancer diagnosis, research, and therapy.

Career Highlights

Throughout his career, Daniel Rhodes has worked with esteemed institutions such as the University of Michigan and Brigham and Women's Hospital, Inc. His research has not only advanced scientific knowledge but has also paved the way for new therapeutic approaches in oncology.

Collaborations

Rhodes has collaborated with notable colleagues, including Scott Tomlins and Arul M Chinnaiyan. These partnerships have further enriched his research and contributed to the advancement of cancer diagnostics and treatment.

Conclusion

In summary, Daniel Rhodes is a distinguished inventor whose work in cancer research has led to significant advancements in understanding gene fusions and variants. His contributions continue to impact the field and offer hope for improved cancer diagnosis and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…